{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:32:44Z","timestamp":1790872364780,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,2]]},"DOI":"10.1097\/qad.0b013e32832ec1c3","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T03:17:41Z","timestamp":1259378261000},"page":"93-99","source":"Crossref","is-referenced-by-count":20,"title":["Antiretroviral treatment changes in adults from C\u00f4te d'Ivoire: the roles of tuberculosis and pregnancy"],"prefix":"10.1097","volume":"24","author":[{"given":"Eug\u00e8ne","family":"Messou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Anglaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Duvignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Konan-N'Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Komena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Gnokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Karcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Tanoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"N'Dri-Yoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Seyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0b013e3282f768f8","article-title":"Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants","volume":"22","author":"Toure","year":"2008","journal-title":"AIDS"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":"Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archinternmed.2007.10","article-title":"Effectiveness of antiretroviral treatment in a South African program: a cohort study","volume":"168","author":"Fairall","year":"2008","journal-title":"Arch Intern Med"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.qai.0000159668.80207.5b","article-title":"Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana","volume":"40","author":"Wester","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/135965350701200508","article-title":"Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort","volume":"12","author":"Boulle","year":"2007","journal-title":"Antivir Ther"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e318033ffa1","article-title":"Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda","volume":"44","author":"Forna","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/QAD.0b013e3281c615da","article-title":"Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa","volume":"21","author":"Seyler","year":"2007","journal-title":"AIDS"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00002030-200303070-00013","article-title":"Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Cote d'Ivoire","volume":"17","author":"Anglaret","year":"2003","journal-title":"AIDS"},{"key":"R13-12-20210130","first-page":"1","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV","volume":"51","author":"Dybul","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/QAD.0b013e3282f09876","article-title":"Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa","volume":"21","author":"Moh","year":"2007","journal-title":"AIDS"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1086\/510078","article-title":"Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis","volume":"44","author":"Manosuthi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.qai.0000219777.04927.50","article-title":"Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa","volume":"42","author":"Danel","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/QAI.0b013e318050d683","article-title":"Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana","volume":"45","author":"Bussmann","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.aids.0000161776.30815.44","article-title":"Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Cote d'Ivoire: a 7-year cohort study","volume":"19","author":"Loko","year":"2005","journal-title":"AIDS"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2471\/BLT.06.032060","article-title":"Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi","volume":"85","author":"Harries","year":"2007","journal-title":"Bull World Health Organ"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1371\/journal.pmed.0040257","article-title":"Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach","volume":"4","author":"Tonwe-Gold","year":"2007","journal-title":"PLoS Med"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-200003310-00005","article-title":"Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients","volume":"14","author":"d'Arminio Monforte","year":"2000","journal-title":"AIDS"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200101260-00007","article-title":"Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre","volume":"15","author":"Mocroft","year":"2001","journal-title":"AIDS"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1468-1293.2001.00045.x","article-title":"Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort","volume":"2","author":"Kirk","year":"2001","journal-title":"HIV Med"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/135965350501000309","article-title":"The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens","volume":"10","author":"Smith","year":"2005","journal-title":"Antivir Ther"},{"key":"R26-12-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","article-title":"Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy","volume":"46","author":"Mutimura","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","article-title":"Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort","volume":"40","author":"Lichtenstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/135965350501000510","article-title":"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire","volume":"10","author":"Moh","year":"2005","journal-title":"Antivir Ther"},{"issue":"Suppl 2","key":"R29-12-20210130","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dieterich","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32832ec1c3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:06:59Z","timestamp":1786039619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201001020-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832ec1c3","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1,2]]}}}